rs33987824

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_018136.5(ASPM):​c.2751C>T​(p.Ala917Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0175 in 1,611,552 control chromosomes in the GnomAD database, including 318 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 13 hom., cov: 32)
Exomes 𝑓: 0.018 ( 305 hom. )

Consequence

ASPM
NM_018136.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.721

Publications

3 publications found
Variant links:
Genes affected
ASPM (HGNC:19048): (assembly factor for spindle microtubules) This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]
ASPM Gene-Disease associations (from GenCC):
  • microcephaly 5, primary, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 1-197129196-G-A is Benign according to our data. Variant chr1-197129196-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136424.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.721 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0134 (2039/152112) while in subpopulation NFE AF = 0.0201 (1366/67958). AF 95% confidence interval is 0.0192. There are 13 homozygotes in GnomAd4. There are 970 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASPMNM_018136.5 linkc.2751C>T p.Ala917Ala synonymous_variant Exon 9 of 28 ENST00000367409.9 NP_060606.3 Q8IZT6-1B3KWI2
ASPMNM_001206846.2 linkc.2751C>T p.Ala917Ala synonymous_variant Exon 9 of 27 NP_001193775.1 Q8IZT6-2B3KWI2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASPMENST00000367409.9 linkc.2751C>T p.Ala917Ala synonymous_variant Exon 9 of 28 1 NM_018136.5 ENSP00000356379.4 Q8IZT6-1

Frequencies

GnomAD3 genomes
AF:
0.0134
AC:
2041
AN:
151994
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00346
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00695
Gnomad ASJ
AF:
0.0311
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00912
Gnomad FIN
AF:
0.0238
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0201
Gnomad OTH
AF:
0.00862
GnomAD2 exomes
AF:
0.0149
AC:
3753
AN:
251078
AF XY:
0.0156
show subpopulations
Gnomad AFR exome
AF:
0.00333
Gnomad AMR exome
AF:
0.00559
Gnomad ASJ exome
AF:
0.0301
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0218
Gnomad NFE exome
AF:
0.0206
Gnomad OTH exome
AF:
0.0152
GnomAD4 exome
AF:
0.0180
AC:
26238
AN:
1459440
Hom.:
305
Cov.:
31
AF XY:
0.0176
AC XY:
12808
AN XY:
726100
show subpopulations
African (AFR)
AF:
0.00239
AC:
80
AN:
33436
American (AMR)
AF:
0.00537
AC:
240
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0309
AC:
807
AN:
26082
East Asian (EAS)
AF:
0.0000759
AC:
3
AN:
39532
South Asian (SAS)
AF:
0.0105
AC:
904
AN:
85964
European-Finnish (FIN)
AF:
0.0211
AC:
1124
AN:
53386
Middle Eastern (MID)
AF:
0.0118
AC:
68
AN:
5752
European-Non Finnish (NFE)
AF:
0.0198
AC:
21985
AN:
1110320
Other (OTH)
AF:
0.0170
AC:
1027
AN:
60276
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1221
2443
3664
4886
6107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0134
AC:
2039
AN:
152112
Hom.:
13
Cov.:
32
AF XY:
0.0130
AC XY:
970
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.00345
AC:
143
AN:
41502
American (AMR)
AF:
0.00694
AC:
106
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0311
AC:
108
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00892
AC:
43
AN:
4818
European-Finnish (FIN)
AF:
0.0238
AC:
252
AN:
10580
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0201
AC:
1366
AN:
67958
Other (OTH)
AF:
0.00853
AC:
18
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
96
193
289
386
482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0179
Hom.:
45
Bravo
AF:
0.0116
Asia WGS
AF:
0.00404
AC:
14
AN:
3476
EpiCase
AF:
0.0171
EpiControl
AF:
0.0185

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 02, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 30, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly 5, primary, autosomal recessive Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
6.2
DANN
Benign
0.66
PhyloP100
-0.72
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33987824; hg19: chr1-197098326; COSMIC: COSV54129985; API